Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus

Biotechnology Letters

Volumn 34, Issue 5, 2012, Pages 839-847

  Fang, Mingli ^a   Li, Jianli ^b,c   Wang, Hua ^a   Yang, Ming ^a   Zhang, Yongsheng ^a   Zhou, Lei ^a   Wei, Hongfei ^a   Yang, Guang ^a   Yu, Yue ^a   Wei, Xuefeng ^d   Yu, Yongli ^a   Wang, Liying ^a   Wan, Min ^a  

^a Basic Medical College   (China)

^b NANJING AGRICULTURAL UNIVERSITY   (China)

^c Tianjin Ringpu Bio technology Co Ltd   (China)

^d Inner Mongolia Jinyu Group Baoling Bio pharmaceutical Corporation   (China)

Author keywords

Foot and mouth disease virus; Recombinant epitope vaccine; RGD sequence of B cell epitope; VP1 capsid protein

Indexed keywords

3D STRUCTURE; B CELLS; CAPSID PROTEINS; FOOT-AND-MOUTH DISEASE VIRUS; GENES CODING; GUINEA PIGS; LOCAL SIMILARITY; NEUTRALIZING ANTIBODIES; RGD SEQUENCES; T-CELL EPITOPES;

ANTIBODIES; ANTIGENS; DISEASES; GENES; MAMMALS; VACCINES; VIRUSES;

RECOMBINANT PROTEINS;

CAPSID PROTEIN; EPITOPE; NEUTRALIZING ANTIBODY; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS VACCINE; VP1 PROTEIN, FOOT AND MOUTH DISEASE VIRUS; VP1 PROTEIN, FOOT-AND-MOUTH DISEASE VIRUS;

ANIMAL; ARTICLE; BLOOD; CATTLE; CATTLE DISEASE; CHEMICAL STRUCTURE; DISEASE MODEL; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENETICS; GUINEA PIG; IMMUNOLOGY; MOUSE; PROTEIN CONFORMATION; SURVIVAL;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CAPSID PROTEINS; CATTLE; CATTLE DISEASES; DISEASE MODELS, ANIMAL; EPITOPES; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GUINEA PIGS; MICE; MODELS, MOLECULAR; PROTEIN CONFORMATION; SURVIVAL ANALYSIS; VACCINES, SYNTHETIC; VIRAL VACCINES;

BOS; BOVINAE; CAVIA; FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE; MUS;

EID: 84862798693     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-012-0856-0     Document Type: Article

References (20)

1. Abdul-Hamid NF, Hussein NM, Wadsworth J et al (2011) Phylogeography of foot-and-mouth disease virus types O and A in Malaysia and surrounding countries. Infect Genet Evol 11: 320-328.
2. Bittle JL, Houghten RA, Alexander H et al (1982) Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298: 30-33.
3. Collen T, Dimarchi R, Doel TR (1991) A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol 146: 749-755.
4. DiMarchi R, Brooke G, Gale C et al (1986) Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232: 639-641.
5. Du Y, Li Y, He H et al (2008) Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon α in mice and protective efficacy in guinea pigs and swine. J Virol Methods 149: 144-152.
6. Gao SD, Du JZ, Chang HY et al (2010) B Cell epitopes within VP1 of type O foot-and-mouth disease virus for detection of viral antibodies. Virol Sin 25: 18-26.
7. He C, Wang H, Wei H et al (2010) A recombinant truncated FMDV 3AB protein used to better distinguish infected and vaccinated cattle. Vaccine 28: 3435-3439.
8. King A, Underwood B, McCahon D et al (1981) Biochemical identification of the viruses causing the 1981 outbreak of foot-and-mouth disease virus in UK. Nature 293: 479-480.
9. Li G, Chen W, Yan W et al (2004) Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes. Virology 328: 274-281.
10. Luis LR, Marvin JG (2009) Foot and mouth disease virus vaccines. Vaccine 27: 90-94.
11. Luizinho C, Mario SB, Mauro PM et al (2005) Granulocyte-macrophage colony-stimulating factor does not increase the potency or efficacy of a foot-and-mouth disease virus subunit vaccine. Pesqui Vet Bras 25: 150-158.
12. Mateu MG, Camarero JA, Giralt E et al (1995) Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 206: 298-306.
13. Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27: 493-497.
14. Rodriguez LL, Barrera J, Kramer E et al (2003) A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine 21: 3751-3756.
15. Shao JJ, Wong CK, Lin T et al (2011) Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine. Clin Vaccine Immunol 18: 143-149.
16. Sirskyi D, Diaz-Mitoma F, Golshani A et al (2011) Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses. Immunol Cell Biol 89: 81-89.
17. Sobrino F, Blanco E, García-Briones M et al (1999) Synthetic peptide vaccines: foot-and-mouth disease virus as a model. Dev Biol Stand 101: 39-43.
18. Wei JC, Huang YZ, Zhong DK et al (2010) Design and evaluation of a multi-epitope peptide against Japanese encephalitis 3 virus infection in BALB/c mice. Biochem Biophys Res Commun 396: 787-792.
19. Zamorano PI, Wigdorovitz A, Pérez Filgueira DM et al (1998) Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1. Vaccine 16: 558-563.
20. Zhang Q, Yang YQ, Zhang ZY et al (2002) Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs. Acta Virol 46: 1-9.